Prokidney to participate in td cowen's 43rd annual health care conference

Winston-salem, n.c., march 03, 2023 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (ckd), today announced that dr. tim bertram, chief executive officer, will present at td cowen's 43 rd annual health care conference on tuesday march 7, 2023 at 10:30 am est.
PROK Ratings Summary
PROK Quant Ranking